+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Arglabin

BP3076
84692-91-1
98%
Phytounique
Arglabin has antiatherogenic effects, it may represent a new promising compound to treat inflammation and type 2 diabetes mellitus development, it can attenuate inflammation, protect pancreatic β-cells from apoptosis, and prevent Type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet. Arglabin shows promising antitumor activity against different tumor cell lines, Arglabin-DMA inhibits cell proliferation of a variety of tumor types with IC(90)s in the range of 0.85 to 5.0 microg/ml. Arglabin is an organic heterotetracyclic compound and guaianolide sesquiterpene lactone that is acrylic acid which is substituted at position 2 by a 4-hydroxy-3,8-dimethyl-1,3a,4,5,6,7-hexahydroazulen-5-yl group in which the double bond in the 7-membered ring has been epoxidised and in which the hydroxy group and the carboxy group have undergone formal condensation to give the corresponding gamma-lactone. It is found in Artemisia glabella.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3076-5mg 5mg
BP3076-10mg 10mg
BP3076-20mg 20mg
BP3076-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

APP CASP1 MAPK1 TNF PIK3CA NFKB1 IL1B NLRP3 IL18
CASP1 MAPK1 TNF PIK3CA NFKB1 IL1B NLRP3 IL18
CASP1 MAPK1 TNF NFKB1 IL1B NLRP3 IL18
MAPK1 TNF PIK3CA NFKB1 NLRP3 KRAS
TNF PIK3CA NFKB1 NRAS NLRP3

Arglabin Related Products

Product drug property prediction parameters

  • 38.8300

  • 2.2242

  • 2.2242

  • .2879

  • 6.3154

  • 7.5739

  • High

  • 56.3561

  • 5.1791

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.9

  • Yes

  • No

  • Yes

  • Yes